From: Association of genetic variants with response to iron supplements in pregnancy
Parameters | Baseline (n = 181) (10–18 weeks) | F1 (n = 161) (18–24 weeks) | F2 (n = 139) (30–36 weeks) | Controls (n = 61) |
---|---|---|---|---|
Age (years) | 22.99 ± 3.12 | 23.1 ± 3.17 | 22.9 ± 3.16 | 22.61 ± 3.58 |
BMI | 20.97 ± 3.76 | NA | NA | 22.21 ± 3.07 |
Hemoglobin (g/dl) | 9.34 ± 1.19 | 10.8 ± 1.27 | 11.4 ± 1.4 | 12.62 ± 1.16 |
MCV (fl) | 70.7 ± 6.7 | 81.3 ± 6.1 | 85.9 ± 6.9 | 86.77 ± 5.37 |
RBC (×106)/μl | 4.2 ± 0.36 | 4.08 ± 0.4 | 3.9 ± 0.41 | 4.2 ± 0.37 |
IRON (μg/dl) | 23 (8–152) | 75 (10–291) | 85 (17–282) | 76 (38–168) |
TIBC (μg/dl) | 412.54 ± 74.2 | 389 (204–651) | 404 (274–581) | 394 ± 59.87 |
TF saturation (%) | 6.69 ± 4.1 | 21.8 ± 13.9 | 22.9 ± 12.9 | 20.9 ± 8.9 |
Ferritin (ng/ml) | 7.2 (0.2–57.4) | 22.4 (1–127) | 26.7 (2.4–218) | 25 (8–79.8) |